Caxton Associates (New York)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-37,345
| Closed | -$87K | – | 630 |
|
|
2022
Q3 | $87K | Buy |
+37,345
| New | +$87K | 0.01% | 432 |
|
|
2020
Q4 | – | Sell |
-41,412
| Closed | -$338K | – | 340 |
|
|
2020
Q3 | $338K | Buy |
+41,412
| New | +$338K | 0.04% | 167 |
|
|
2020
Q1 | – | Sell |
-56,029
| Closed | -$489K | – | 631 |
|
|
2019
Q4 | $489K | Buy |
+56,029
| New | +$489K | 0.07% | 168 |
|